市場調查報告書 - 248192

全球美容外科手術市場

Global Markets For Aesthetic Products In 2012
出版商 Life Science Intelligence, Inc.
出版日期 2012年08月07日 內容資訊 英文 142 Pages
價格
全球美容外科手術市場 Global Markets For Aesthetic Products In 2012
出版日期: 2012年08月07日 內容資訊: 英文 142 Pages
簡介

全球美容設備市場2011年達到約43億美金。近幾年市場變動，2009年呈現減少趨勢，但2011年達到史上最高的銷售額。這主要是由於作為容貌的改善，以及擁有年輕外表方式的美容外科手術的人氣高漲。亞洲及南美市場崛起也促進銷售額。因此，市場在預測期間內將維持高銷售額，全球市場2017年將達到78億美元的市場規模。

本報告提供全球美容外科手術市場相關調查，手術類型，治療器，地區等不同市場區隔的分析及主要企業簡介，為您概述為以下內容。

第1章 摘要整理

第2章 美容移植

  • 產品類型
    • 豐胸手術
    • 臉部移植
    • 其他身體移植
    • 乳房重建用組織擴張器
  • 手術數預測·市場分析
    • 美國
    • 歐洲
    • 其他
    • 美國以外的供應商的市場佔有率

第3章 皮膚填充劑&神經調節物質

  • 產品類型
  • 手術數預測·市場分析
    • 美國
    • 歐洲
    • 其他
    • 美國以外的供應商的市場佔有率

第4章 雷射，光療設備&其他的能量治療設備

  • 產品類型
  • 美容用雷射，光療設備&其他的能量治療設備的優點與缺點
  • 手術數預測·市場分析
    • 美國
    • 美國以外的手術數預測·市場分析

第5章 企業簡介

  • Allergan
  • Alma Lasers
  • AngioDynamics
  • biolitec
  • Covidien
  • Cutera
  • Cynosure
  • El. En.
  • Galderma
  • GC Aesthetics
  • Lumenis
  • Medicis Pharmaceutical
  • Mentor Worldwide (Johnson & Johnson)
  • Merz Aesthetics
  • Palomar Medical Technologies
  • PhotoMedex
  • sanofi-aventis
  • Silimed
  • Solta Medical
  • Syneron Medical
  • ZELTIQ Aesthetics
目錄

Abstract

Overview

image1

The global market for the aesthetic devices analyzed in this report was valued at nearly $4.3 billion in 2011. The market has fluctuated in recent years and saw declines in 2009. The year 2011, however, was marked by higher sales volumes than in historical years, largely due to the growing popularity of aesthetic procedures as a means to improve appearance or restore a youthful look as well as the growing availability of non-surgical treatments. The emergence of markets in Asia and South America has also helped to boost sales. These factors will contribute to higher sales volumes throughout the forecast period, and in 2017, the global market is expected to reach a value of $7.8 billion.

This report provides a deep and detailed analysis of: implants, dermal fillers, neuromodulators, and lasers, light-based systems, and other energy-based devices.

Find out which segments will account for the greatest share, as well as which regions will exceed a 14% CAGR, through 2017.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1 Aesthetic Implants
  • 1.2 Dermal Fillers & Neuromodulators
  • 1.3 Lasers, Light-Based Systems, and Other Energy-Based Devices
  • Exhibit 1-1: The Global Market for Aesthetic Devices by Product Type from 2010-2017
  • Exhibit 1-2: The Global Market for Aesthetic Devices by Region from 2010-2017
  • Exhibit 1-3: The Global Market Forecast for Aesthetic Implants by Type from 2010-2017
  • Exhibit 1-4: The Global Market Forecast for Aesthetic Implants by Region from 2010-2017
  • Exhibit 1-5: The Global Market Forecast for Dermal Fillers and Neuromodulators from 2010-2017
  • Exhibit 1-6: The Global Market Forecast for Dermal Fillers and Neuromodulators by Region from 2010-2017
  • Exhibit 1-7: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
  • Exhibit 1-8: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Region from 2010-2017

2. AESTHETIC IMPLANTS

  • 2.1 Types of Products
    • 2.1.1 Breast Implants
    • 2.1.2 Facial Implants
    • 2.1.3 Other Bodily Implants
    • 2.1.4 Tissue Expanders for Breast Reconstructions
  • 2.2 Procedure Forecasts and Market Analyses
    • 2.2.1 U.S. Procedure Forecasts and Market Analyses
      • 2.2.1.1 Breast Augmentation
      • 2.2.1.2 Facial Implants
      • 2.2.1.3 Other Bodily Implants
      • 2.2.1.4 Breast Reconstruction
      • 2.2.1.5 U.S. Supplier Shares
    • 2.2.2 European Procedure Forecasts and Market Analyses
      • 2.2.2.1 Breast Augmentation
      • 2.2.2.2 Facial Implants
      • 2.2.2.3 Other Bodily Implants
      • 2.2.2.4 Breast Reconstruction
    • 2.2.3 Procedure Forecasts and Market Analyses for Countries in Asia-Pacific and the Rest-of-the-World
      • 2.2.3.1 Breast Augmentation
      • 2.2.3.2 Facial Implants
      • 2.2.3.3 Other Bodily Implants
      • 2.2.3.4 Breast Reconstruction
    • 2.2.4 OUS Supplier Shares
  • Exhibit 2-1: Types of Aesthetic Implants
  • Exhibit 2-2: Selected Aesthetic Implants in 2012
  • Exhibit 2-3: The Global Market Forecast for Aesthetic Implants from 2010-2017
  • Exhibit 2-4: The U.S. Market Forecast for Aesthetic Implants from 2010-2017
  • Exhibit 2-5: The U.S. Market Forecast for Aesthetic Implants by Type from 2010-2017
  • Exhibit 2-6: The U.S. Market Forecast for Breast Augmentation from 2010-2017
  • Exhibit 2-7: The U.S. Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017
  • Exhibit 2-8: The U.S. Market Forecast for Facial Implants from 2010-2017
  • Exhibit 2-9: The U.S. Market Forecast for Other Bodily Implants from 2010-2017
  • Exhibit 2-10: The U.S. Market Forecast for Breast Reconstructions from 2010-2017
  • Exhibit 2-11: U.S. Supplier Shares in 2010 and 2011
  • Exhibit 2-12: The European Market Forecast for Aesthetic Implants from 2010-2017
  • Exhibit 2-13: The European Market Forecast for Aesthetic Implants by Type from 2010-2017
  • Exhibit 2-14: The European Market Forecast for Breast Augmentation from 2010-2017
  • Exhibit 2-15: The European Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017
  • Exhibit 2-16: The European Market Forecast for Facial Implants from 2010-2017
  • Exhibit 2-17: The European Market Forecast for Other Bodily Implants from 2010-2017
  • Exhibit 2-18: The European Market Forecast for Breast Reconstructions from 2010-2017
  • Exhibit 2-19: The AP & ROW Market Forecast for Aesthetic Implants from 2010-2017
  • Exhibit 2-20: The AP & ROW Market Forecast for Aesthetic Implants by Type from 2010-2017
  • Exhibit 2-21: The AP & ROW Market Forecast for Breast Augmentation from 2010-2017
  • Exhibit 2-22: The AP & ROW Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017
  • Exhibit 2-23: The AP & ROW Market Forecast for Facial Implants from 2010-2017
  • Exhibit 2-24: The AP & ROW Market Forecast for Other Bodily Implants from 2010-2017
  • Exhibit 2-25: The AP & ROW Market Forecast for Breast Reconstructions from 2010-2017
  • Exhibit 2-26: OUS Supplier Shares in 2010 and 2011

3. DERMAL FILLERS & NEUROMODULATORS

  • 3.1 Product Types
  • 3.2 Procedure Forecasts and Market Analyses
    • 3.2.1 U.S. Procedure Forecasts and Market Analyses
      • 3.2.1.1 Dermal Fillers
      • 3.2.1.2 Neuromodulators
      • 3.2.1.3 U.S. Supplier Shares
    • 3.2.2 European Procedure Forecasts and Market Analyses
      • 3.2.2.1 Dermal Fillers
      • 3.2.2.2 Neuromodulators
    • 3.2.3 Procedure Forecasts and Market Analyses for Countries in Asia-Pacific and the Rest-of-the-World
      • 3.2.3.1 Dermal Fillers
      • 3.2.3.2 Neuromodulators
    • 3.2.4 OUS Supplier Shares
  • Exhibit 3-1: Dermal Fillers & Neuromodulators
  • Exhibit 3-2: Advantages & Disadvantages of Dermal Fillers & Neuromodulators
  • Exhibit 3-3: Selected Dermal Fillers & Neuromodulators in 2012
  • Exhibit 3-4: The Global Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
  • Exhibit 3-5: The U.S. Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
  • Exhibit 3-6: The U.S. Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017
  • Exhibit 3-7: The U.S. Market Forecast for Dermal Fillers from 2010-2017
  • Exhibit 3-8: The U.S. Market Forecast for Neuromodulators from 2010-2017
  • Exhibit 3-9: U.S. Supplier Shares in 2010 and 2011
  • Exhibit 3-10: The European Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
  • Exhibit 3-11: The European Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017
  • Exhibit 3-12: The European Market Forecast for Dermal Fillers from 2010-2017
  • Exhibit 3-13: The European Market Forecast for Neuromodulators from 2010-2017
  • Exhibit 3-14: The AP & ROW Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
  • Exhibit 3-15: The AP & ROW Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017
  • Exhibit 3-16: The AP & ROW Market Forecast for Dermal Fillers from 2010-2017
  • Exhibit 3-17: The AP & ROW Market Forecast for Neuromodulators from 2010-2017
  • Exhibit 3-18: OUS Supplier Shares in 2010 and 2011

4. LASERS, LIGHT-BASED SYSTEMS, & OTHER ENERGY-BASED DEVICES

  • 4.1 Product Types
  • 4.2 Advantages and Disadvantages of Lasers, Light-Based Systems, and Other Energy-Based Devices for Aesthetic Applications
  • 4.3 Procedure Forecasts and Market Analyses
    • 4.3.1 U.S. Procedure Forecasts and Market Analyses
      • 4.3.1.1 Lasers, Light-Based, and Other Energy-Based Systems
      • 4.3.1.2 Endovenous Vein Ablations
      • 4.3.1.3 U.S. Supplier Shares
    • 4.3.2 OUS Procedure Forecasts and Market Analyses
      • 4.3.2.1 European Procedure Forecasts and Market Analyses
        • 4.3.2.1.1 Lasers, Light-, and Other Energy-Based Systems
        • 4.3.2.1.2 Endovenous Vein Ablations
      • 4.3.2.2 AP & ROW Procedure Forecasts and Market Analyses
        • 4.3.2.2.1 Lasers, Light-, and Other Energy-Based Systems
        • 4.3.2.2.2 Endovenous Vein Ablations
      • 4.3.2.3 OUS Supplier Shares
  • Exhibit 4-1: Selected Lasers, Light-Based Systems, and Other Energy-Based Devices in 2012
  • Exhibit 4-2: Advantages & Disadvantages of Lasers, Light-Based Systems, and Other Energy-Based Devices for Aesthetic Procedures
  • Exhibit 4-3: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
  • Exhibit 4-4: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Geography from 2010-2017
  • Exhibit 4-5: The U.S. Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
  • Exhibit 4-6: The U.S. Forecast for Aesthetic Procedures Using Lasers, Light-Based Systems, & Other Energy-Based Devices from 2010-2017
  • Exhibit 4-7: The U.S. Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; & Cryolipolysis
  • Exhibit 4-8: Endovenous Vein Ablations in the U.S. from 2010-2017
  • Exhibit 4-9: The U.S. Market Forecast for Endovenous Vein Ablations from 2010-2017
  • Exhibit 4-10: U.S. Supplier Shares in 2010 and 2011
  • Exhibit 4-11: The European Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
  • Exhibit 4-12: The European Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; & Cryolipolysis
  • Exhibit 4-13: Endovenous Vein Ablations in Europe from 2010-2017
  • Exhibit 4-14: The European Market Forecast for Endovenous Vein Ablations from 2010-2017
  • Exhibit 4-15: The AP & ROW Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
  • Exhibit 4-16: The AP & ROW Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; & Cryolipolysis
  • Exhibit 4-17: Endovenous Vein Ablations in AP & ROW Countries from 2010-2017
  • Exhibit 4-18: The AP & ROW Market Forecast for Endovenous Vein Ablations from 2010-2017
  • Exhibit 4-19: OUS Supplier Shares in 2010 and 2011

5. COMPANY PROFILES

  • 5.1 Allergan
  • 5.2 Alma Lasers
  • 5.3 AngioDynamics
  • 5.4 biolitec
  • 5.5 Covidien
  • 5.6 Cutera
  • 5.7 Cynosure
  • 5.8 El. En.
  • 5.9 Galderma
  • 5.10 GC Aesthetics
  • 5.11 Lumenis
  • 5.12 Medicis Pharmaceutical
  • 5.13 Mentor Worldwide (Johnson & Johnson)
  • 5.14 Merz Aesthetics
  • 5.15 Palomar Medical Technologies
  • 5.16 PhotoMedex
  • 5.17 sanofi-aventis
  • 5.18 Silimed
  • 5.19 Solta Medical
  • 5.20 Syneron Medical
  • 5.21 ZELTIQ Aesthetics

Companies

  • Allergan
  • Alma Lasers
  • AngioDynamics
  • biolitec
  • Covidien
  • Cutera
  • Cynosure
  • El. En.
  • Galderma
  • GC Aesthetics
  • Lumenis
  • Medicis Pharmaceutical
  • Mentor Worldwide (Johnson & Johnson)
  • Merz Aesthetics
  • Palomar Medical Technologies
  • PhotoMedex
  • sanofi-aventis
  • Silimed
  • Solta Medical
  • Syneron Medical
  • ZELTIQ Aesthetics
新聞稿

全球美容設備市場預計在2017年將達到78億美元的規模

2012年08月21日

Global Information, Inc.開始銷售Life Science Intelligence, Inc.所發行的報告書「Global Markets For Aesthetic Products In 2012 (全球美容外科手術市場)」

根據Life Science Intelligence公司指出，全球美容設備市場在2011年達到約43億美元的規模。

該市場近年來持續變化，2009年雖然一時衰退，但在2011年卻寫下了過去最高的銷售額記錄。這是因為非外科治療的選擇擴大，消費者為了提升外表容貌及恢復青春讓美容手術更受歡迎，還有亞洲及南美新興市場銷售額的增大，使得該市場得以擴大。一般預測到2017年將達到78億美金的規模。

本市場調查報告書提供全球美容外科手術市場相關資料調查及分析，以移植、皮膚填充劑、神經調質，雷射光照射裝置，以及其他能源活用設備為焦點，及主要企業簡介詳細報告。

Life Science Intelligence, Inc.總公司設置於美國加州，是專擅於整形外科、腦外科、及關節移植等領域的調查公司。

全球美容外科手術市場是由出版商Life Science Intelligence, Inc.在2012年08月07日所出版的。這份市場調查報告書包含142 Pages 價格從美金2000起跳。
Back to Top
;